Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies
延长吡托布替尼暴露治疗复发和/或难治性B细胞恶性肿瘤的安全性
期刊:Acta Haematologica
影响因子:1.1
doi:10.1159/000539587
Roeker, Lindsey E; Coombs, Catherine C; Shah, Nirav N; Jurczak, Wojciech; Woyach, Jennifer A; Cheah, Chan Y; Patel, Krish; Maddocks, Kami; Wang, Yucai; Zinzani, Pier Luigi; Munir, Talha; Koh, Youngil; Thompson, Meghan C; Muehlenbein, Catherine E; Wang, Chunxiao; Sizelove, Richard; Abhyankar, Sarang; Hasanabba, Safarulla; Tsai, Donald E; Eyre, Toby A; Wang, Michael